Stevanato Group (NYSE:STVN) Rating Increased to Strong-Buy at Stephens

Stephens upgraded shares of Stevanato Group (NYSE:STVN) to a strong-buy rating in a research report released on Monday,Zacks.com reports.

Other research analysts have also issued reports about the stock. William Blair restated an “outperform” rating on shares of Stevanato Group in a research report on Friday, March 7th. UBS Group cut their target price on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating for the company in a research note on Friday, March 7th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of €25.70 ($29.20).

Stevanato Group Stock Performance

NYSE:STVN opened at €21.86 ($24.84) on Monday. The company has a fifty day simple moving average of €20.69 and a two-hundred day simple moving average of €20.72. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. Stevanato Group has a 52 week low of €16.56 ($18.82) and a 52 week high of €28.77 ($32.69). The company has a market cap of $6.62 billion, a price-to-earnings ratio of 46.51, a price-to-earnings-growth ratio of 7.18 and a beta of 0.52.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) EPS for the quarter, hitting the consensus estimate of €0.20 ($0.23). The firm had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. As a group, equities analysts anticipate that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Stevanato Group

Institutional investors have recently modified their holdings of the business. Van Berkom & Associates Inc. bought a new stake in shares of Stevanato Group during the 4th quarter worth $39,000. Johnson Financial Group Inc. bought a new position in shares of Stevanato Group during the 4th quarter worth about $41,000. Wells Fargo & Company MN raised its position in shares of Stevanato Group by 680.3% during the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company’s stock worth $71,000 after purchasing an additional 2,830 shares during the period. PNC Financial Services Group Inc. boosted its stake in Stevanato Group by 1,457.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company’s stock valued at $123,000 after purchasing an additional 5,291 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in shares of Stevanato Group by 202.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company’s stock worth $162,000 after acquiring an additional 4,965 shares in the last quarter.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.